| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 470,000 | 461,000 | 414,000 | 376,000 | | Cost of Revenue | 279,000 | 321,000 | 283,000 | 286,000 | | | Gross Profit | 191,000 | 140,000 | 131,000 | 90,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 32,000 | 35,000 | 31,000 | 33,000 | | Non Recurring |
-
| 2,000 | 1,000 | (3,000) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 159,000 | 103,000 | 99,000 | 60,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,000 | 11,000 |
-
| (3,000) | | Earnings Before Interest And Taxes | 175,000 | 129,000 | 99,000 | 57,000 | | Interest Expense | 38,000 | 43,000 | 35,000 | 34,000 | | Income Before Tax | 137,000 | 86,000 | 64,000 | 23,000 | | Income Tax Expense | (20,000) | (9,000) | (5,000) | (8,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 157,000 | 95,000 | 69,000 | 31,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 157,000 | 95,000 | 69,000 | 31,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $157,000 | $95,000 | $69,000 | $31,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
